This DoD grant is for supporting new ideas and innovative approaches in prostate cancer research with the potential to significantly contribute to the Prostate Cancer Research Program (PCRP) mission. It encourages groundbreaking studies, even those with inherent risk, provided they are based on sound scientific rationale. While preliminary data is welcome, it’s not mandatory, emphasizing innovation. The grant encompasses basic, population-based, translational, and clinical research. Applicants must address PCRP focus areas and are highly encouraged to tackle overarching challenges, or justify critical needs. A ‘New Investigator Option’ allows early-career researchers to compete in a separate category, with collaboration strongly encouraged to strengthen proposals.
Opportunity ID: 234313
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-PCRP-IDA |
| Funding Opportunity Title: | DoD FY13 Prostate Cancer Idea Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 32 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 13, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 02, 2013 |
| Current Closing Date for Applications: | Oct 02, 2013 |
| Archive Date: | Nov 01, 2013 |
| Estimated Total Program Funding: | $17,300,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The PCRP Idea Development Award mechanism was first offered in FY97. Since then, 5,748 Idea Development Award applications have been received, and 1,029 have been recommended for funding. The Idea Development Award supports new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to the PCRP mission. Although groundbreaking research often involves a degree of risk, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature. Due to this awards emphasis on innovation, the presentation of preliminary data relevant to prostate cancer and the proposed project is encouraged but not required. Research deemed innovative may represent a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research that is an incremental advance upon published data is not considered innovative. The PCRP seeks applications from the wide spectrum of basic, population-based, translational, and clinical research. In addition, applicants are expected to address at least one of the PCRP focus areas and are highly encouraged to address one of the PCRP overarching challenges. If the proposed project does not address any of the overarching challenges, the application should include a description to justify how the project will nevertheless address a critical need in the field of prostate cancer research and/or patient care. New Investigator Option: The FY13 Idea Development Award mechanism encourages applications from investigators in the early stages of their careers. The New Investigator Option is designed to allow applicants early in their faculty appointments, or in the process of developing independent research careers, to compete for funding separately from established investigators. Applications from New Investigators and Established Investigators will be peer- and programmatically reviewed in separate groups. PIs using the New Investigator Option are strongly encouraged to strengthen their applications through collaboration with investigators experienced in prostate cancer research and/or possessing other relevant expertise. It is the responsibility of the PI to describe how collaboration will augment his or her expertise to best address the research question. All applicants for the New Investigator Option must meet specific eligibility criteria as described in Section I.C., Eligibility Information. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
301-682-5507 Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 234313 Full Announcement-1 -> pcrp fy13 ida-nio eligibility statement_gg.pdf
Folder 234313 Full Announcement-1 -> pcrp fy13 ida-nio statement of independence_gg.pdf
Folder 234313 Full Announcement-1 -> pcrp fy13 ida pa_gg.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk 301-682-5507 Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00177530 | May 13, 2013 | Oct 02, 2013 | View |
Package 1
Mandatory forms
234313 RR_SF424_1_2-1.2.pdf
234313 PerformanceSite_1_4-1.4.pdf
234313 RR_Budget-1.1.pdf
234313 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
234313 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
